News (16)

Sep 16, - Johnson & Johnson Announces Agreement To Acquire Alios BioPharma
Sep 16, - Johnson & Johnson Announces Completion Of Alios Biopharma Acquisition
Aug 16, 2016Boston Tech Flash - Vasculox changes name, hires new CEO and raises $86 million
Aug 16, 2016Xconomy - With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy
Nov 18, 2015PRNewswire UK All - New Data Published in the New England Journal of Medicine Shows Potential of Compound to Fight RSV Infection in Adults and Children
Oct 16, 2015Business Wire - Medivir Announces That Janssen Has Started a Phase IIa Study to Evaluate the Effect of simeprevir in Combination with odalasvir and AL-335
Apr 23, 2015Business Wire - Janssen Announces SVR12 Rates with Twelve Weeks of Treatment with All-Oral, Once-Daily Regimen of Simeprevir ▼ Plus Sofosbuvir ▼ in Genotype 1 HCV Patients With and Without Cirrhosis
Oct 10, 2014Fierce Biotech - Gilead wins FDA approval for its hep C combo pill, a blockbuster in the making
Oct 1, 2014Xconomy - Alios's Corporate Venture Backers Ride RSV (And Hep C) To Big Payday
Sep 30, 2014Fierce Biotech - J&J makes a splash in hep C with a $1.75B deal for Alios
Sep 30, - Johnson & Johnson expands viral disease pipeline with $1.75-billion deal for AliosBioPharma
Apr 7, 2014FinSMEs - FinSMEs
Nov 2, 2012Xconomy - East Coast Life Sciences Roundup: Vertex, Thermedical, More
Jun 11, 2009Market Wired - Top - Alios BioPharma, Inc. Closes $32 Million Series A Financing
Apr 17, - Alios BioPharma raises 24000000 in venture round
Feb 9, 2009PE HUB - Alios BioPharma Raises $8.4 Million